Levy Harkins & Co’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$9.53M Sell
118,824
-11,425
-9% -$942K 2.43% 14
2017
Q4
$10.5M Sell
130,249
-3,915
-3% -$314K 3.26% 15
2017
Q3
$10.4M Buy
134,164
+5,546
+4% +$460K 3.43% 14
2017
Q2
$11.4M Sell
128,618
-1,375
-1% -$116K 3.98% 11
2017
Q1
$10.5M Buy
129,993
+10,353
+9% +$809K 3.81% 12
2016
Q4
$8.52M Sell
119,640
-1,590
-1% -$125K 3.25% 15
2016
Q3
$10.5M Buy
121,230
+1,075
+0.9% +$93.7K 4.14% 10
2016
Q2
$10.4M Sell
120,155
-4,950
-4% -$400K 4.72% 8
2016
Q1
$9.38M Sell
125,105
-8,395
-6% -$632K 3.98% 10
2015
Q4
$10.3M Buy
133,500
+1,755
+1% +$132K 4.53% 9
2015
Q3
$6.58M Sell
131,745
-1,345
-1% -$99.1K 3.6% 16
2015
Q2
$9.86M Buy
+133,090
New +$10.2M 3.96% 16
2014
Q4
$9.75M Sell
135,067
-105
-0.1% -$7.29K 3.99% 16
2014
Q3
$8.37M Sell
135,172
-23,605
-15% -$1.5M 3.39% 18
2014
Q2
$10.1M Buy
158,777
+7,332
+5% +$445K 3.55% 17
2014
Q1
$9.32M Sell
151,445
-2,110
-1% -$123K 3.38% 19
2013
Q4
$8.81M Buy
153,555
+7,640
+5% +$433K 3.21% 19
2013
Q3
$7.77M Sell
145,915
-9,705
-6% -$522K 3.09% 19
2013
Q2
$8.01M Buy
+155,620
New +$7.69M 3.42% 18

Other funds holding MDT

Levy Harkins & Co's MDT Position: Q1 2018 in Review

Levy Harkins & Co reduced its Medtronic (MDT) stake by 8.8% in Q1 2018, selling an estimated $942K and leaving 118,824 shares worth $9.53M. The position accounts for 2.43% of the portfolio, ranked #14.

Levy Harkins & Co first reported a position in MDT in Q2 2013 and has held it in 19 quarters since. The position peaked at $11.4M in Q2 2017. 1,382 funds tracked by Wall St. Rank hold MDT as of Q1 2018.

  • Levy Harkins & Co held 118,824 shares of Medtronic worth $9.53M as of Q1 2018.
  • Levy Harkins & Co sold 11,425 Medtronic shares in Q1 2018, an estimated $942K.
  • Medtronic made up 2.43% of Levy Harkins & Co's portfolio in Q1 2018, its #14 holding.
  • Levy Harkins & Co first reported a position in Medtronic in Q2 2013 and has held it in 19 quarters since.
  • Levy Harkins & Co's Medtronic position peaked at $11.4M in Q2 2017.
  • 1,382 funds tracked by Wall St. Rank held Medtronic as of Q1 2018.

Based on Levy Harkins & Co's 13F filing for Q1 2018, filed 26 Apr 2018.